References
Sankar A, Mudaliar R, Kochhar R et al. The importance of glycaemic control before bariatric surgery: preventing microvascular and metabolic complications. Obes Surg. 2024.
Fountain D, Alkharaiji M, Awad S, et al. Idris I Prevalence of co-morbidities in a specialist weight management programme prior to bariatric surgery. British J of Diabetes. 2019;19:8–13.
Wilmington R, Abuawwad M, Holt G et al. The effects of preoperative glycaemic control (HbA1c) on bariatric and metabolic surgery outcomes: data from a tertiary-referral bariatric centre in the UK. Obes Surg. 2024.
Ferrannini E, Mingrone G. Impact of differential bariatric surgical procedures on insulin action and β-cell function in type 2 diabetes. Diabetes Care. 2009;32:514–20.
Richardson P, Hulpus A, Idris I. Short-term impact of bariatric surgery on best-corrected distance visual acuity and diabetic retinopathy progression. Obes Surg. 2018;28(11):3711–3.
Vilsbøll T, Bain SC, Leiter LA, et al. Semaglutide, reduction in glycated haemoglobin and the risk of diabetic retinopathy. Diabetes Obes Metab. 2018;20(4):889–97.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Wilmington, R., Abuawwad, M., Holt, G. et al. The Effects of Preoperative Glycaemic Control (HbA1c) on Bariatric and Metabolic Surgery Outcomes: Data from a Tertiary-Referral Bariatric Centre in the UK. OBES SURG (2024). https://doi.org/10.1007/s11695-024-07120-9
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11695-024-07120-9